CR Bard Earns $2.54 per Share

Another good earnings report from CR Bard (BCR). For Q2, the company earned $2.54 per share. They had given us a range of $2.43 to $2.47 per share. Quarterly sales rose 8% to $931.5 million. Not including forex, sales were up 9%.

Timothy M. Ring, chairman and chief executive officer, commented, “We continue to see strong results as we prioritize product leadership across the globe. Our commitment to innovation and product differentiation, along with a focus on delivering economic benefits to the healthcare system, have driven global demand for our products, and our targeted investments in emerging markets continue to expand our presence internationally. We believe this investment approach positions us well to continue to provide attractive returns to our shareholders.”

Now for guidance. Bard sees full-year earnings coming in between $10.10 and $10.20 per share. That’s an increase from the previous guidance of $10.05 to $10.18 per share.

Update: On the earnings call, Bard gave of range of $2.51 to $2.55 for Q3.

Posted by on July 26th, 2016 at 4:22 pm


The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.